AI-generated summary
In a mouse model of bleomycin-induced pulmonary fibrosis, the authors report that low-level laser therapy at 780 nm reduced inflammatory cell migration and collagen deposition in the lungs. They also report lower pro-inflammatory cytokines, higher IL-10 and reduced total lung TGFβ in cell and animal experiments. The study was conducted in mice and cell cultures, so its relevance to human disease is unclear.
- Who or what was studied
- C57Bl/6 mice with bleomycin-induced lung fibrosis, plus in vitro bleomycin-activated fibroblasts and type II pneumocytes
- Wavelengths
- 780 nm
- Limits stated in the abstract
- The study was conducted in a murine model and in vitro cell assays, and the abstract reports no human data.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 780 nm
- Power
- 30 mW
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Low-level laser therapy, Laser, Inflammation, Collagen. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.